Credit Suisse said UnitedHealth's (UNH) acquisition of Catamaran (CTRX) improves its PBM offering, and if it can retain the customer base, will ultimately grow market shares. The firm raised UnitedHealth's price target to $135 and reiterates its Outperform rating.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here